OMERS Administration Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38M Buy
50,580
+3,279
+7% +$314K 0.03% 276
2025
Q4
$4.54M Hold
47,301
0.03% 186
2025
Q3
$4.5M Hold
47,301
0.03% 201
2025
Q2
$4.12M Hold
47,301
0.03% 194
2025
Q1
$4.25M Sell
47,301
-9,083
-16% -$813K 0.04% 191
2024
Q4
$4.5M Buy
56,384
+9,200
+19% +$796K 0.04% 167
2024
Q3
$4.25M Buy
47,184
+1,100
+2% +$92.5K 0.04% 186
2024
Q2
$3.63M Buy
+46,084
New +$3.78M 0.03% 204
2021
Q4
Sell
-89,497
Closed -$11.2M 416
2021
Q3
$11.2M Buy
+89,497
New +$11.6M 0.16% 59
2021
Q2
Sell
-73,139
Closed -$8.64M 69
2021
Q1
$8.64M Sell
73,139
-69,981
-49% -$8.2M 0.14% 62
2020
Q4
$16.8M Sell
143,120
-74,108
-34% -$8.16M 0.3% 60
2020
Q3
$22.6M Hold
217,228
0.48% 49
2020
Q2
$19.9M Buy
217,228
+168,341
+344% +$16.1M 0.66% 50
2020
Q1
$4.41M Sell
48,887
-944,603
-95% -$100M 0.2% 53
2019
Q4
$113M Sell
993,490
-137,200
-12% -$15.1M 1.3% 29
2019
Q3
$123M Sell
1,130,690
-6,500
-0.6% -$678K 1.22% 28
2019
Q2
$112M Buy
1,137,190
+93,660
+9% +$8.55M 1.17% 29
2019
Q1
$98.5M Buy
1,043,530
+218,570
+26% +$19.6M 1.13% 34
2018
Q4
$75M Sell
824,960
-198,300
-19% -$18.5M 0.99% 39
2018
Q3
$101M Buy
1,023,260
+77,430
+8% +$7.16M 0.96% 34
2018
Q2
$81M Buy
945,830
+696,130
+279% +$58.1M 0.75% 38
2018
Q1
$20M Buy
+249,700
New +$20.6M 0.19% 59
2016
Q3
Sell
-269,945
Closed -$23.4M 630
2016
Q2
$23.4M Sell
269,945
-577,555
-68% -$46.7M 0.48% 44
2016
Q1
$63.6M Buy
847,500
+57,700
+7% +$4.35M 1.41% 27
2015
Q4
$60.8M Buy
789,800
+113,100
+17% +$8.51M 1.57% 15
2015
Q3
$45.3M Buy
676,700
+335,250
+98% +$24.7M 1.32% 17
2015
Q2
$25.3M Sell
341,450
-518,550
-60% -$39.6M 1% 19
2015
Q1
$67.1M Sell
860,000
-46,600
-5% -$3.53M 2.52% 8
2014
Q4
$65.5M Buy
906,600
+46,600
+5% +$3.24M 1.98% 12
2014
Q3
$53.3M Buy
+860,000
New +$54.7M 1.59% 16

Other funds holding MDT

OMERS Administration Corp's MDT Position: Q1 2026 in Review

OMERS Administration Corp increased its Medtronic (MDT) stake by 6.9% in Q1 2026, buying an estimated $314K and bringing the position to 50,580 shares worth $4.38M. The position accounts for 0.03% of the portfolio, ranked #276.

OMERS Administration Corp first reported a position in MDT in Q3 2014 and has held it in 30 quarters since. The position peaked at $123M in Q3 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • OMERS Administration Corp held 50,580 shares of Medtronic worth $4.38M as of Q1 2026.
  • OMERS Administration Corp bought 3,279 Medtronic shares in Q1 2026, an estimated $314K.
  • Medtronic made up 0.03% of OMERS Administration Corp's portfolio in Q1 2026, its #276 holding.
  • OMERS Administration Corp first reported a position in Medtronic in Q3 2014 and has held it in 30 quarters since.
  • OMERS Administration Corp's Medtronic position peaked at $123M in Q3 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.